[Bora] Announcement of Board Resolution on Cash Capital Increase for Subsidiary Bora Pharmaceuticals USA Inc.
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Bora announced a USD 122.5 million cash capital increase for its subsidiary Bora Pharmaceuticals USA Inc., to be allocated as a capital reserve to strengthen operations and change the business model. This is a related party transaction.